Here are five news updates on key gastroenterology and endoscopy companies.
Exact Sciences, the company behind Cologuard, stock has received an average rating of "buy" from 14 analyst firms, according to a Dakota Financial News report.
Gilead Sciences is in the process of evaluating its approved hepatitis C drug Sovaldi used in combination with the experimental NS5A inhibitor velpatasvir. The once-daily, fixed dose combination of drugs is showing promise for treating all forms of hepatitis C.
Modernizing Medicine, the developer of Electronic Medical Assistant, closed a $38 million Series E financing round. The company now has $87 million in capital.
HOYA Group PENTAX Medical acquired an interest in Creo Medical, a U.K.-based electrosurgical energy devices company. PENTAX has identified therapeutic endoscopy devices as a priority for its new investment.
PENTAX Medical released the latest update of its endoPRO iQ, information technology and image management software for endoscopy units.
If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at cpallardy@beckershealthcare.com.